Novartis Transderm Scop relaunch to include mailing to consumers who called while product was unavailable.
Executive Summary
NOVARTIS TRANSDERM SCOP RE-LAUNCH WILL BEGIN WITH DIRECT MAIL campaign to health care professionals in September. The campaign will be directed to a database of callers who previously contacted Novartis' toll-free number requesting the scopolamine 1.5 mg patch for motion sickness. Direct mailings to consumers in the database will follow in November. The patch will be promoted by Novartis' consumer products division.